Massive Bio Unveils Groundbreaking Oncology/Hematology AI Platform at ASCO 2024: Revolutionizing Oncology/Hematology with AI Driven Personalized Insights for Clinical Trial Accessibility

Massive Bio’s Co-Founder and CMO, Dr. Arturo Loaiza-Bonilla, to Speak at Precision Med Tri-Con 2024 in San Diego

Selin Kurnaz will speak at the prestigious Global Private Equity Conference

Massive Bio Shines at Revo Capital’s 4th Building Bridges Event

Massive Bio’s CEO Selin Kurnaz on SCOPE Summit

Selin Kurnaz Leads Massive Bio to Pioneering Heights in Global Cancer Care 

American Cancer Society Highlights Massive Bio’s Chief Medical Officer, Arturo LoAIza-Bonilla 

Massive Bio’s Co-Founder Dr. Arturo Loaiza-Bonilla Participates in Europe’s Leading Health Tech Event 

Further Group Collaborates with Massive Bio, Integrating Health Solutions for the Insurance Industry to Boost Access to Cancer Clinical Trials Globally  

Massive Bio and Health in Code Collaborate to Enhance Personalized Oncology Treatment Through Advanced Genomic Testing